<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR37">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Muller</surname>
    <given-names>MP</given-names>
   </name>
   <name>
    <surname>Dresser</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Raboud</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>McGeer</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Rea</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Richardson</surname>
    <given-names>SE</given-names>
   </name>
   <name>
    <surname>Mazzulli</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Loeb</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Louie</surname>
    <given-names>M</given-names>
   </name>
   <collab>Canadian SARS Research Network</collab>
  </person-group>
  <article-title>Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome</article-title>
  <source>Pharmacotherapy</source>
  <year>2007</year>
  <volume>27</volume>
  <issue>4</issue>
  <fpage>494</fpage>
  <lpage>503</lpage>
  <pub-id pub-id-type="doi">10.1592/phco.27.4.494</pub-id>
  <pub-id pub-id-type="pmid">17381375</pub-id>
 </element-citation>
</ref>
